Effect of Yiqihuoxue prescription on myocardial energy metabolism after myocardial infarction via cross talk of liver kinase B1-dependent Notch1 and adenosine 5'-monophosphate-activated protein kinase.

CONCLUSION: YQHX promoted cross talk between the LKB1-dependent Notch1 and AMPK in myocardial tissue after myocardial infarction. Furthermore, it regulated the glucose and lipid metabolism of cardiomyocytes at different time points, thereby ameliorating the cardiac energy metabolism via different mechanisms and protecting the heart. PMID: 31682381 [PubMed]
Source: Journal of Traditional Chinese Medicine - Category: Complementary Medicine Authors: Tags: J Tradit Chin Med Source Type: research

Related Links:

A HEART attack could be prevented by sipping on a certain type of juice alongside your meals. What's the research behind this life-saving drink? Here's what you need to know.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Publication date: October 2020Source: Archives of Cardiovascular Diseases Supplements, Volume 12, Issues 2–4Author(s): G. Bourdier, V. Delgado, S. Robelet
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Publication date: October 2020Source: Archives of Cardiovascular Diseases Supplements, Volume 12, Issues 2–4Author(s): W. Heyse, V. Vandewalle, P. Amouyel, G. Marot, C. Bauters, F. Pinet
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Publication date: October 2020Source: Archives of Cardiovascular Diseases Supplements, Volume 12, Issues 2–4Author(s): J. Lugrin, R. Parapanov, G. Milano, T. Krueger, L. Liaudet
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Publication date: October 2020Source: Archives of Cardiovascular Diseases Supplements, Volume 12, Issues 2–4Author(s): A. Acheampong, G. Hubesch, C. Watu, K. Mc Entee, P. Van De Borne
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Publication date: October 2020Source: Archives of Cardiovascular Diseases Supplements, Volume 12, Issues 2–4Author(s): M. Goninet, C. Bergerot, C. Amaz, C. De Bourguignon, T. Bochaton, M. Ovize, H. Thibault, N. Mewton
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Condition:   Acute Coronary Syndrome Intervention:   Drug: beta-blocker Sponsor:   Chongqing Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Myocardial Infarction;   Heart Failure Interventions:   Drug: Dapagliflozin;   Drug: Placebo Sponsors:   AstraZeneca;   Uppsala University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Acute Coronary Syndrome Intervention:   Drug: beta-blocker Sponsor:   Chongqing Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Acute Myocardial Infarction;   Heart Failure Interventions:   Drug: Dapagliflozin;   Drug: Placebo Sponsors:   AstraZeneca;   Uppsala University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | China Health | Complementary Medicine | Heart | Heart Attack | Liver | Urology & Nephrology